Principal Financial Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-13,144
| Closed | -$1.22M | – | 2620 |
|
|
2021
Q4 | $1.22M | Sell |
13,144
-5,040
| -28% | -$332K | ﹤0.01% | 1946 |
|
|
2021
Q3 | $1.08M | Sell |
18,184
-3,027
| -14% | -$179K | ﹤0.01% | 1988 |
|
|
2021
Q2 | $1.45M | Buy |
21,211
+1,751
| +9% | +$114K | ﹤0.01% | 1973 |
|
|
2021
Q1 | $1.35M | Buy |
19,460
+2,730
| +16% | +$210K | ﹤0.01% | 1931 |
|
|
2020
Q4 | $1.28M | Buy |
16,730
+1,380
| +9% | +$103K | ﹤0.01% | 1886 |
|
|
2020
Q3 | $1.15M | Sell |
15,350
-2,171
| -12% | -$145K | ﹤0.01% | 1843 |
|
|
2020
Q2 | $1.1M | Buy |
17,521
+3,538
| +25% | +$195K | ﹤0.01% | 1815 |
|
|
2020
Q1 | $587K | Buy |
13,983
+739
| +6% | +$33.9K | ﹤0.01% | 1836 |
|
|
2019
Q4 | $601K | Sell |
13,244
-1,406
| -10% | -$66.5K | ﹤0.01% | 1912 |
|
|
2019
Q3 | $671K | Buy |
14,650
+1,353
| +10% | +$76.1K | ﹤0.01% | 1891 |
|
|
2019
Q2 | $780K | Sell |
13,297
-601
| -4% | -$31.1K | ﹤0.01% | 1879 |
|
|
2019
Q1 | $623K | Buy |
13,898
+387
| +3% | +$17.8K | ﹤0.01% | 1893 |
|
|
2018
Q4 | $526K | Sell |
13,511
-1,420
| -10% | -$55.8K | ﹤0.01% | 1909 |
|
|
2018
Q3 | $687K | Buy |
14,931
+1,932
| +15% | +$78.3K | ﹤0.01% | 1906 |
|
|
2018
Q2 | $566K | Sell |
12,999
-17,236
| -57% | -$741K | ﹤0.01% | 1948 |
|
|
2018
Q1 | $1.19M | Buy |
30,235
+1,543
| +5% | +$60K | ﹤0.01% | 1800 |
|
|
2017
Q4 | $975K | Buy |
+28,692
| New | +$817K | ﹤0.01% | 1844 |
|
|
2017
Q2 | – | Sell |
-4,470
| Closed | -$65K | – | 2308 |
|
|
2017
Q1 | $65K | Hold |
4,470
| – | – | ﹤0.01% | 2165 |
|
|
2016
Q4 | $63K | Buy |
4,470
+235
| +6% | +$3.64K | ﹤0.01% | 2185 |
|
|
2016
Q3 | $74K | Hold |
4,235
| – | – | ﹤0.01% | 2126 |
|
|
2016
Q2 | $72K | Hold |
4,235
| – | – | ﹤0.01% | 2115 |
|
|
2016
Q1 | $83K | Buy |
4,235
+140
| +3% | +$2.24K | ﹤0.01% | 2099 |
|
|
2015
Q4 | $78K | Hold |
4,095
| – | – | ﹤0.01% | 2125 |
|
|
2015
Q3 | $78K | Buy |
4,095
+445
| +12% | +$15.1K | ﹤0.01% | 2109 |
|
|
2015
Q2 | $169K | Sell |
3,650
-241
| -6% | -$10.5K | ﹤0.01% | 2070 |
|
|
2015
Q1 | $171K | Buy |
3,891
+358
| +10% | +$16.6K | ﹤0.01% | 2054 |
|
|
2014
Q4 | $123K | Sell |
3,533
-1,033
| -23% | -$41.9K | ﹤0.01% | 2095 |
|
|
2014
Q3 | $191K | Hold |
4,566
| – | – | ﹤0.01% | 2039 |
|
|
2014
Q2 | $268K | Sell |
4,566
-2,509
| -35% | -$158K | ﹤0.01% | 2001 |
|
|
2014
Q1 | $446K | Buy |
7,075
+1,042
| +17% | +$69.1K | ﹤0.01% | 1886 |
|
|
2013
Q4 | $353K | Sell |
6,033
-1,113
| -16% | -$58.2K | ﹤0.01% | 1950 |
|
|
2013
Q3 | $377K | Buy |
7,146
+1,223
| +21% | +$82.1K | ﹤0.01% | 1901 |
|
|
2013
Q2 | $456K | Buy |
+5,923
| New | +$484K | ﹤0.01% | 1850 |
|
Principal Financial Group's ARNA Position: Q1 2022 in Review
Principal Financial Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 13,144 shares — an estimated $1.22M sold.
Principal Financial Group first reported a position in ARNA in Q2 2013 and held it in 33 quarters. The position peaked at $1.45M in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Principal Financial Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Principal Financial Group sold 13,144 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.22M.
- Principal Financial Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
- Principal Financial Group's Arena Pharmaceuticals Inc position peaked at $1.45M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Principal Financial Group's 13F filing for Q1 2022, filed 9 May 2022.